<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02133638</url>
  </required_header>
  <id_info>
    <org_study_id>Sev003</org_study_id>
    <secondary_id>s100b</secondary_id>
    <nct_id>NCT02133638</nct_id>
  </id_info>
  <brief_title>Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery</brief_title>
  <official_title>Sevoflurane-based Volatile Induction and Maintenance of Anaesthesia (VIMA) Strategy Decreases the Risk of Postoperative Delirium in Elderly Patients With Registered Cerebral Hypoxemia Episodes During General Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Negovsky Reanimatology Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Negovsky Reanimatology Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to distinguish possible differences in frequency of delirium after
      Volatile Induction and Maintenance of Anesthesia and Total Intravenous Anesthesia in case of
      undeliberate cerebral desaturation during non-cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the present study is to investigate whether in non-cardiac surgery the frequency
      of POD after intraoperative undeliberate cerebral saturation could be modulated by the choice
      of the anesthetic strategy (Volatile Induction and Maintenance of Anesthesia [VIMA] and Total
      Intravenous Anesthesia [TIVA]). Based on our previous data we hypothesized that incidence of
      POD would be lower with VIMA compared to TIVA.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Regional Cerebral Oxygenation (rSO2)</measure>
    <time_frame>Continued the entire surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral tissue oxygen saturation (SpO2)</measure>
    <time_frame>Continued the entire surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-invasive blood pressure (NIBP)</measure>
    <time_frame>Continued the entire surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Incidences of postoperative delirium (POD)</measure>
    <time_frame>Baseline, 24h and 48h after surgery</time_frame>
    <description>Applying the Confusion Assessment Method for the ICU (CAM-ICU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma concentration of S100b protein</measure>
    <time_frame>Baseline, 24h and 48h after surgery</time_frame>
    <description>S100b protein is the neuronal injury marker</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Cerebral Hypoxia</condition>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sevoflurane Based Volatile Induction and Maintenance of Anaesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol Based Total Intravenous Anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Induction of anesthesia: fentanyl 2 µg kg-1 and a bolus inhalation of 8% sevoflurane in an 8 L.min-1 fresh gas flow. Anesthesia maintenance: 1 minimal alveolar concentration (MAC) sevoflurane at a low fresh gas flow of 0.6-0.8 L min-1 in a 60% air-oxygen mixture supplemented with boluses of fentanyl.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <other_name>Sevorane</other_name>
    <other_name>Ultane</other_name>
    <other_name>Fluoromethyl hexafluoroisopropyl ether</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Induction of anesthesia: propofol 2 mg kg-1 and fentanyl 4 µg kg-1. Maintenance of anesthesia: infusion of propofol 8 mg kg-1 h-1 and boluses of fentanyl 3 µg kg-1.</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Diprivan</other_name>
    <other_name>Lipuro</other_name>
    <other_name>Propolipid</other_name>
    <other_name>Propoven</other_name>
    <other_name>Recofol</other_name>
    <other_name>Unifol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  class III-IV by physical status classification system of American Society of
             Anesthesiologist (ASA)

          -  history of arterial vascular disease (arterial hypertension, myocardial ischemia
             and/or cerebral vascular disease)

          -  undergoing elective non-cardiac surgery (hemicolectomy, hernioplasty, laparoscopic
             cholecystectomy and laparoscopic hysterectomy)

        Exclusion Criteria:

          -  dementia

          -  stroke or myocardial infarction ≤ 6 months before surgery

          -  oncological disease of T2-4N3M1 stage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valery V. Likhvantsev, MD, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Negovsky Reanimatology Research Institute, Moscow, Russia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oleg A. Grebenchikov, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Negovsky Reanimatology Research Institute, Moscow, Russia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuri V. Iljin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Negovsky Reanimatology Research Institute, Moscow, Russia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander V. Mironenko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Negovsky Reanimatology Research Institute, Moscow, Russia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuri V. Skripkin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Negovsky Reanimatology Research Institute, Moscow, Russia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dmitriy B. Selivanov, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Maria Vittoria, Turin, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valery V. Likhvantsev, MD, Prof.</last_name>
    <email>lik0704@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical center of the Main Administration for Service to the Diplomatic Corps</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuri V. Skripkin</last_name>
      <email>skripkin62@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2014</study_first_submitted>
  <study_first_submitted_qc>May 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2014</study_first_posted>
  <last_update_submitted>May 6, 2014</last_update_submitted>
  <last_update_submitted_qc>May 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Delirium</keyword>
  <keyword>Hypoxic Brain Damage</keyword>
  <keyword>Propofol</keyword>
  <keyword>S100b protein</keyword>
  <keyword>Sevoflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Hypoxia, Brain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

